United States Biotechnology & Medical Research

Parabilis Medicines Inc (PBLS)

Parabilis Medicines Inc experienced significant buying activity between June and July 2026. RA Capital Management, L.P., along with other insiders, executed multiple purchase transactions. The most recent acquisition occurred on July 22, 2026. These insider trading transactions represent the final recorded market movements for the firm during this period.
Ticker: PBLS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Parabilis Medicines Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
373.30
Quantity 54,786 -7.0%
Value US$4,831,818
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
334.12
Quantity 2,976 +5.0%
Value US$377,320
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
219.71
Quantity 80,351 -30.2%
Value US$1,261,482
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
27.96
Quantity 21,696 +0.1%
Value US$606,620
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
27.72
Quantity 32,987 +0.1%
Value US$914,400
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
27.13
Quantity 98,433 +0.4%
Value US$2,670,487
3.2
SEBULSKY ALAN Non-Executive Director
Transaction date
Purchase
Price
27.10
Quantity 4,065 +15.7%
Value US$110,146
3.2
SEBULSKY ALAN Non-Executive Director
Transaction date
Purchase
Price
26.00
Quantity 5,000 +23.9%
Value US$129,989
3.2
SEBULSKY ALAN Non-Executive Director
Transaction date
Purchase
Price
27.67
Quantity 8,435 +67.5%
Value US$233,393
2.3
Levy Guy Large shareholder
Transaction date
Purchase
Price
20.00
Quantity 125,000 +23.7%
Value US$2,500,000
2.3
Levy Guy Large shareholder
Transaction date
Purchase
Price
20.00
Quantity 375,000 +57.5%
Value US$7,500,000
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
20.00
Quantity 1,460,397 +122.9%
Value US$29,207,940
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
20.00
Quantity 19,728,353 +300.9%
Value US$394,567,060
3.2
SEBULSKY ALAN Non-Executive Director
Transaction date
Purchase
Price
20.00
Quantity 12,500 New position
Value US$250,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-22 2026-07-22 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
54,786 -7.0%
373.30
US$4,831,818 		54,786 -7.0% 373.30 US$4,831,818
2026-07-22 2026-07-21 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
2,976 +5.0%
334.12
US$377,320 		2,976 +5.0% 334.12 US$377,320
2026-07-22 2026-07-21 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
80,351 -30.2%
219.71
US$1,261,482 		80,351 -30.2% 219.71 US$1,261,482
2026-07-22 2026-07-21 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
21,696 +0.1%
27.96
US$606,620 		21,696 +0.1% 27.96 US$606,620
2026-07-22 2026-07-20 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
32,987 +0.1%
27.72
US$914,400 		32,987 +0.1% 27.72 US$914,400
2026-07-22 2026-07-20 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
98,433 +0.4%
27.13
US$2,670,487 		98,433 +0.4% 27.13 US$2,670,487
2026-06-16 2026-06-15 B Purchase
3.2
SEBULSKY ALAN
Non-Executive Director
4,065 +15.7%
27.10
US$110,146 		4,065 +15.7% 27.10 US$110,146
2026-06-16 2026-06-15 B Purchase
3.2
SEBULSKY ALAN
Non-Executive Director
5,000 +23.9%
26.00
US$129,989 		5,000 +23.9% 26.00 US$129,989
2026-06-16 2026-06-12 B Purchase
3.2
SEBULSKY ALAN
Non-Executive Director
8,435 +67.5%
27.67
US$233,393 		8,435 +67.5% 27.67 US$233,393
2026-06-29 2026-06-11 B Purchase
2.3
Levy Guy
Large shareholder
125,000 +23.7%
20.00
US$2,500,000 		125,000 +23.7% 20.00 US$2,500,000
2026-06-29 2026-06-11 B Purchase
2.3
Levy Guy
Large shareholder
375,000 +57.5%
20.00
US$7,500,000 		375,000 +57.5% 20.00 US$7,500,000
2026-06-15 2026-06-11 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,460,397 +122.9%
20.00
US$29,207,940 		1,460,397 +122.9% 20.00 US$29,207,940
2026-06-15 2026-06-11 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
19,728,353 +300.9%
20.00
US$394,567,060 		19,728,353 +300.9% 20.00 US$394,567,060
2026-06-15 2026-06-11 B Purchase
3.2
SEBULSKY ALAN
Non-Executive Director
12,500 New position
20.00
US$250,000 		12,500 New position 20.00 US$250,000
Explore more

More insider trading research around Parabilis Medicines Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America